Travere Therapeutics, Inc.TVTXNASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P10
Near historical low
vs 3Y Ago
-33.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -182.76% |
| Q3 2025 | 307.14% |
| Q2 2025 | 70.21% |
| Q1 2025 | 35.62% |
| Q4 2024 | -4.29% |
| Q3 2024 | 23.08% |
| Q2 2024 | 48.30% |
| Q1 2024 | -49.15% |
| Q4 2023 | -19.19% |
| Q3 2023 | 12.39% |
| Q2 2023 | 11.02% |
| Q1 2023 | -23.30% |
| Q4 2022 | 5.50% |
| Q3 2022 | -3.81% |
| Q2 2022 | 12.50% |
| Q1 2022 | -42.86% |
| Q4 2021 | -42.37% |
| Q3 2021 | 7.81% |
| Q2 2021 | 33.33% |
| Q1 2021 | 59.49% |
| Q4 2020 | -438.64% |
| Q3 2020 | 24.14% |
| Q2 2020 | -3000.00% |
| Q1 2020 | 102.86% |
| Q4 2019 | 17.65% |
| Q3 2019 | 7.61% |
| Q2 2019 | 7.07% |
| Q1 2019 | -450.00% |
| Q4 2018 | 86.57% |
| Q3 2018 | -139.29% |
| Q2 2018 | -21.74% |
| Q1 2018 | -2.22% |
| Q4 2017 | 2.17% |
| Q3 2017 | -35.29% |
| Q2 2017 | -17.24% |
| Q1 2017 | -26.09% |
| Q4 2016 | 77.00% |
| Q3 2016 | -170.27% |
| Q2 2016 | -219.35% |
| Q1 2016 | 555.21% |